fresh frozen plasma + prothrombin complex concentrate

The combination of fresh frozen plasma (FFP) and prothrombin complex concentrate (PCC) is a therapeutic regimen used primarily for the emergent reversal of vitamin K antagonist (e.g., warfarin) therapy and the management of major bleeding or urgent surgical procedures in patients with coagulopathy. PCC provides a rapid, concentrated source of vitamin K-dependent clotting factors (Factors II, VII, IX, and X), allowing for faster correction of the International Normalized Ratio (INR) with a significantly lower infusion volume compared to FFP alone. FFP is often co-administered to provide a comprehensive range of all coagulation factors, including Factor V and Factor XI, which may be deficient in certain PCC formulations, and to assist in volume expansion during massive hemorrhage protocols. This synergistic approach ensures both rapid restoration of the prothrombin complex and broad replacement of the entire coagulation cascade.

Brand names

BalfaxarPlexane

Other names

FFP + PCCplasma and prothrombin complex concentratefresh frozen plasma and prothrombin complex concentrate